U.S. Tech Hardware Stock News

Easterly Government Properties (DEA) has wrapped up FY 2025 with Q4 total revenue of US$88.6 million, basic EPS of US$0.10 and funds from operations of US$36.4 million, giving investors a fresh read on cash generation from its government focused portfolio. The company has seen quarterly revenue move from US$79.9 million in Q4 2024 to US$88.6 million in Q4 2025, while basic EPS shifted from US$0.13 to US$0.10 over the same period. Trailing twelve month revenue sits at US$342.9 million with...

Shoals Technologies Group (SHLS) has wrapped up FY 2025 with fourth quarter revenue of US$148.3 million and basic EPS of US$0.05. The company reported trailing twelve month revenue of US$475.3 million and basic EPS of US$0.20, reflecting a 39.2% rise in earnings over the prior year. Quarterly revenue increased from US$106.99 million in Q4 2024 to US$148.3 million in Q4 2025, while quarterly basic EPS held steady at US$0.05 over the same period. This sets the context for a trailing net margin...

Ryman Hospitality Properties (RHP) has wrapped up FY 2025 with Q4 total revenue of US$727.8 million, basic EPS of US$1.17 and net income of US$73.8 million, supported by Funds From Operations of US$145.4 million and FFO per share of US$2.29. Over recent quarters, the company has reported revenue in a range from US$587.3 million to US$727.8 million, while basic EPS has moved between US$0.55 and US$1.17. Quarterly FFO has run between US$105.1 million and US$145.4 million, giving investors a...

Vertex (VERX) has released its fourth quarter and full year 2025 results, reporting higher quarterly revenue compared with the prior year and a shift from a full year net loss to net income, along with new 2026 revenue guidance. See our latest analysis for Vertex. The earnings release and 2026 revenue guidance arrive after a volatile period for Vertex. A 1-day share price return of 10.22% and 7-day share price return of 7.46% contrast with a 30-day share price return decline of 32.69% and a...

Planet Fitness (PLNT) has just wrapped up FY 2025 with fourth quarter revenue of US$376.3 million and basic EPS of US$0.73, alongside net income excluding extra items of US$60.4 million, putting a clean set of headline numbers in front of investors. The company has seen quarterly revenue move from US$320.97 million and EPS of US$0.56 in Q4 2024 to US$376.3 million and EPS of US$0.73 in Q4 2025. This frames a year where trailing twelve month revenue reached about US$1.3 billion and EPS came in...

During the fourth quarter of 2025, Baker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares, an estimated US$53.42 million investment, while the company’s lead retinal drug candidates tarcocimab and KSI-501 continued Phase 3 trials targeting the anti-VEGF market. This combination of heightened institutional interest and late-stage clinical progress positions Kodiak Sciences at a pivotal moment in its attempt to compete in a roughly US$15 billion retinal therapy...

Clarivate (CLVT) has rounded out FY 2025 with Q4 revenue of US$617 million and basic EPS of US$0.00, translating into net income of US$3.1 million. Over the past six quarters, the company has seen quarterly revenue move between US$593.7 million and US$663 million while basic EPS ranged from a loss of US$0.27 to the Q4 FY 2025 level, as net income swung between a loss of US$191.8 million and a small profit. For investors, the key question now is whether this earnings profile can support...

Orthofix Medical (OFIX) has just posted its FY 2025 fourth quarter scorecard, reporting revenue of US$219.9 million and a basic EPS loss of US$0.06. Trailing 12 month revenue stands at US$822.3 million against a net loss of US$92.2 million. Over the past few quarters, the company has reported revenue increasing from US$193.6 million in Q1 2025 to US$219.9 million in Q4 2025, while basic EPS losses narrowed from US$1.35 to US$0.06. This outlines an earnings story that remains marked by...

Helix Energy Solutions Group (HLX) has wrapped up FY 2025 with fourth quarter revenue of US$334.2 million and basic EPS of US$0.06, alongside net income of US$8.3 million. On a trailing twelve month basis the company generated US$1.3 billion of revenue and EPS of US$0.21 from net income of US$30.8 million. Over the last few quarters the business has seen revenue move between US$278.1 million and US$377.0 million, with quarterly EPS ranging from a small loss of about US$0.02 to a recent high...

Interface (TILE) closed out FY 2025 with Q4 revenue of US$349.4 million and basic EPS of US$0.42, while trailing twelve month EPS reached US$1.99 on revenue of about US$1.4 billion, setting a clear earnings and sales backdrop for investors. Over the past few quarters, the company has seen revenue move from US$335.0 million in Q4 2024 to US$375.5 million in Q2 2025 and then to US$349.4 million in Q4 2025, with basic EPS ranging from US$0.22 in Q1 2025 to US$0.79 in Q3 2025, giving a view of...

Backblaze FY 2025 Earnings Snapshot Backblaze (BLZE) has closed out FY 2025 with Q4 revenue of US$37.8 million and a basic EPS loss of US$0.09, while the trailing twelve months show revenue of US$145.8 million and a basic EPS loss of US$0.46, keeping the focus squarely on the path toward profitability. The company has seen quarterly revenue move from US$32.6 million in Q3 FY 2024 to US$37.8 million in Q4 FY 2025, with basic EPS losses narrowing from US$0.29 to US$0.09 over the same span as...

Quaker Chemical (KWR) closed out FY 2025 with Q4 revenue of US$468.5 million and basic EPS of US$1.20, alongside net income of US$20.8 million. Over the last few quarters, the company has seen revenue move from US$444.1 million and EPS of US$0.80 in Q4 2024 to a high of US$493.8 million and EPS of US$1.75 in Q3 2025, before landing at the latest Q4 figures. Trailing twelve month EPS sat at a slight loss of US$0.14 on revenue of about US$1.9 billion. For investors, this set of results puts the...

Innovex International (INVX) just posted its FY 2025 numbers, with Q4 revenue of US$273.6 million and basic EPS of US$0.20. This sets the tone for a year where trailing twelve month revenue reached US$978.3 million and EPS came in at US$1.21, as earnings growth over the last 12 months turned negative compared to earlier periods. The company has seen revenue move from US$660.8 million and EPS of US$2.82 on a trailing basis in FY 2024 to the latest trailing figures. These now sit alongside a...

Bed Bath & Beyond (BBBY) has reported FY 2025 fourth quarter revenue of US$273.4 million with a basic EPS loss of US$0.30, alongside trailing twelve month revenue of US$1.0 billion and a basic EPS loss of US$1.41. The company has seen quarterly revenue move from US$303.2 million in Q4 2024 to US$231.7 million in Q1 2025, US$282.3 million in Q2, US$257.2 million in Q3 and US$273.4 million in Q4, while quarterly basic EPS losses ranged from US$1.66 a share in Q4 2024 to US$0.74, US$0.34,...

Xometry (XMTR) has wrapped up FY 2025 with Q4 revenue of US$192.4 million and a basic EPS loss of US$0.17, alongside net income excluding extra items of a US$8.6 million loss. The company has seen revenue move from US$148.5 million in Q4 2024 to US$192.4 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.17. This sets up a results season in which investors will focus squarely on how quickly margins can tighten toward profitability. See our full...

Westlake Chemical Partners (WLKP) has wrapped up FY 2025 with Q4 revenue of US$323.0 million and EPS of US$0.41, with trailing twelve month revenue at US$1.2 billion and EPS of US$1.38 framing the latest numbers. The company has seen quarterly revenue range from US$237.6 million to US$323.0 million over the year while EPS moved from US$0.14 in Q1 2025 to around US$0.41 in each of the last three quarters, setting up a picture where net margin compression and softer earnings trends are key...

Apellis Pharmaceuticals (APLS) capped FY 2025 with Q4 revenue of US$199.9 million and basic EPS of US$0.47 loss, alongside a net loss of US$59.0 million. On a trailing twelve month basis, the company booked revenue of US$1.0 billion and basic EPS of US$0.18 profit. Over the past year, revenue has moved from US$781.4 million to US$1.0 billion on a trailing basis, with EPS shifting from a loss of US$1.60 to a profit of US$0.18. This sets up a story where investors may weigh sustained revenue...

Haverty Furniture Companies posts steady FY 2025 finish with higher Q4 earnings Haverty Furniture Companies (HVT) has wrapped up FY 2025 with Q4 revenue of US$201.9 million and basic EPS of US$0.52, alongside net income of US$8.5 million, setting a clear marker for how the year closed. The company has seen quarterly revenue move from US$175.9 million in Q3 FY 2024 to US$201.9 million in Q4 FY 2025, while basic EPS shifted from US$0.30 to US$0.52 over the same stretch, giving investors a...

HealthStream (HSTM) closed out FY 2025 with Q4 revenue of US$79.7 million and basic EPS of US$0.09, alongside trailing 12 month revenue of US$304.1 million and EPS of US$0.61 that frame the latest quarter in a broader earnings context. Over recent periods, the company has seen revenue move from US$291.6 million on a trailing basis after Q4 2024 to US$304.1 million after Q4 2025, while trailing EPS shifted from US$0.66 to US$0.61, setting up a picture where earnings forecasts and valuation...

Erie Indemnity (ERIE) closed out FY 2025 with fourth quarter revenue of US$951.0 million and basic EPS of US$1.21, while trailing twelve month revenue stood at about US$4.1 billion and EPS at US$10.70. Together, these figures set the scene for a year in which margins and earnings quality will be front of mind for investors. The company has seen quarterly revenue move from US$924.1 million and EPS of US$3.29 in Q4 2024 to US$951.0 million and EPS of US$1.21 in Q4 2025. Those shifts, alongside...

If you are trying to figure out whether RXO is attractively priced right now, it helps to separate the share price story from the underlying valuation story. RXO closed at US$14.84 recently, with a small 0.1% move over the last week, a 4.6% decline over the past month, a 15.6% gain year to date, and a 25.5% decline over the past year. Recent price moves have put RXO back on the radar as investors reassess transportation and logistics names in light of sector specific news flow and changing...

Diversified Healthcare Trust (DHC) closed FY 2025 with Q4 revenue of US$379.6 million and a basic EPS loss of US$0.09, while trailing twelve month revenue came in at about US$1.5 billion with a basic EPS loss of US$1.19. The company has seen quarterly revenue hold in a tight band between US$373.6 million and US$388.7 million from Q3 2024 through Q4 2025, alongside basic EPS results ranging from a US$0.04 loss to a US$0.68 loss per quarter. This sets the scene for investors to focus closely on...

ACV Auctions (ACVA) has wrapped up FY 2025 with Q4 revenue of US$183.6 million and a basic EPS loss of US$0.11, while trailing twelve month revenue came in at US$759.6 million with a basic EPS loss of US$0.39. The company has seen revenue move from US$159.5 million in Q4 2024 to US$183.6 million in Q4 2025, with quarterly EPS losses ranging between US$0.04 and US$0.16 over the past six reported quarters. This sets the stage for investors to focus on how quickly those losses might narrow...

Novanta (NOVT) has wrapped up FY 2025 with fourth quarter revenue of US$258.3 million and basic EPS of US$0.46, alongside net income of US$17.5 million, setting the tone for how investors will read its latest earnings update. The company has seen quarterly revenue move from US$238.1 million and EPS of US$0.46 in Q4 2024 to US$258.3 million and EPS of US$0.46 in Q4 2025. Trailing twelve month net income of US$53.8 million on revenue of US$980.6 million provides the broader backdrop. With net...